BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33543026)

  • 1. Deregulated expression of Elastin Microfibril Interfacer 2 (EMILIN2) in gastric cancer affects tumor growth and angiogenesis.
    Andreuzzi E; Fejza A; Capuano A; Poletto E; Pivetta E; Doliana R; Pellicani R; Favero A; Maiero S; Fornasarig M; Cannizzaro R; Iozzo RV; Spessotto P; Mongiat M
    Matrix Biol Plus; 2020 May; 6-7():100029. PubMed ID: 33543026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emilin2 fosters vascular stability by promoting pericyte recruitment.
    Fejza A; Camicia L; Carobolante G; Poletto E; Paulitti A; Schinello G; Di Siena E; Cannizzaro R; Iozzo RV; Baldassarre G; Andreuzzi E; Spessotto P; Mongiat M
    Matrix Biol; 2023 Sep; 122():18-32. PubMed ID: 37579864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extracellular matrix glycoprotein elastin microfibril interface located protein 2: a dual role in the tumor microenvironment.
    Mongiat M; Marastoni S; Ligresti G; Lorenzon E; Schiappacassi M; Perris R; Frustaci S; Colombatti A
    Neoplasia; 2010 Apr; 12(4):294-304. PubMed ID: 20360940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMILIN2 (Elastin microfibril interface located protein), potential modifier of thrombosis.
    Sa Q; Hoover-Plow JL
    Thromb J; 2011 May; 9():9. PubMed ID: 21569335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ablation of the matricellular protein EMILIN2 causes defective vascularization due to impaired EGFR-dependent IL-8 production affecting tumor growth.
    Paulitti A; Andreuzzi E; Bizzotto D; Pellicani R; Tarticchio G; Marastoni S; Pastrello C; Jurisica I; Ligresti G; Bucciotti F; Doliana R; Colladel R; Braghetta P; Poletto E; Di Silvestre A; Bressan G; Colombatti A; Bonaldo P; Mongiat M
    Oncogene; 2018 Jun; 37(25):3399-3414. PubMed ID: 29483644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexity of matrix phenotypes.
    Iozzo RV; Theocharis AD; Neill T; Karamanos NK
    Matrix Biol Plus; 2020 May; 6-7():100038. PubMed ID: 33543032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased EMILIN2 correlates to metabolism phenotype and poor prognosis of ovarian cancer.
    Tang X; Li F
    J Biochem; 2022 Jul; 172(2):89-97. PubMed ID: 35588228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulated Elastin Microfibril Interfacer 1 Expression in the Pulmonary Vasculature of Experimental Congenital Diaphragmatic Hernia.
    Zimmer J; Takahashi T; Hofmann AD; Puri P
    Eur J Pediatr Surg; 2018 Feb; 28(1):115-119. PubMed ID: 28701001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an interstitial 18p11.32-p11.31 duplication including the EMILIN2 gene in a family with porokeratosis of Mibelli.
    Occella C; Bleidl D; Nozza P; Mascelli S; Raso A; Gimelli G; Gimelli S; Tassano E
    PLoS One; 2013; 8(4):e61311. PubMed ID: 23593459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the extrinsic apoptotic pathway by the extracellular matrix glycoprotein EMILIN2.
    Mongiat M; Ligresti G; Marastoni S; Lorenzon E; Doliana R; Colombatti A
    Mol Cell Biol; 2007 Oct; 27(20):7176-87. PubMed ID: 17698584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMILIN2 regulates platelet activation, thrombus formation, and clot retraction.
    Huang M; Sannaningaiah D; Zhao N; Gong Y; Grondolsky J; Hoover-Plow J
    PLoS One; 2015; 10(2):e0115284. PubMed ID: 25658937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association study of the elastin microfibril interfacer 1 (EMILIN1) gene in essential hypertension.
    Shimodaira M; Nakayama T; Sato N; Naganuma T; Yamaguchi M; Aoi N; Sato M; Izumi Y; Soma M; Matsumoto K
    Am J Hypertens; 2010 May; 23(5):547-55. PubMed ID: 20186130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo.
    Lang SA; Klein D; Moser C; Gaumann A; Glockzin G; Dahlke MH; Dietmaier W; Bolder U; Schlitt HJ; Geissler EK; Stoeltzing O
    Mol Cancer Ther; 2007 Mar; 6(3):1123-32. PubMed ID: 17363505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimerin-2 maintains vascular stability and permeability.
    Pellicani R; Poletto E; Andreuzzi E; Paulitti A; Doliana R; Bizzotto D; Braghetta P; Colladel R; Tarticchio G; Sabatelli P; Bucciotti F; Bressan G; Iozzo RV; Colombatti A; Bonaldo P; Mongiat M
    Matrix Biol; 2020 May; 87():11-25. PubMed ID: 31422156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
    Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
    Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma.
    Kim R; Emi M; Arihiro K; Tanabe K; Uchida Y; Toge T
    Cancer; 2005 May; 103(9):1800-9. PubMed ID: 15786421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
    Manu KA; Shanmugam MK; Ramachandran L; Li F; Fong CW; Kumar AP; Tan P; Sethi G
    Clin Cancer Res; 2012 Apr; 18(8):2220-9. PubMed ID: 22351692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma.
    Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Cancer; 1999 Oct; 86(8):1455-62. PubMed ID: 10526273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
    Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
    J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.